Atlas Trials

Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC

Clinical trial NCT07476001 · RECRUITING

Trial details

NCT number
NCT07476001
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Castration-resistant Prostate Cancer
Start date
2026-03-03
Primary completion
2027-09-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.